Solubilizing effect of nucleotides on isolated insulin secretory granules.
D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002021:Buffers; D002499:Centrifugation, Density Gradient; D002712:Chlorides / Q000494:pharmacology; D003470:Culture Media; D000242:Cyclic AMP / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D009243:NAD / Q000494:pharmacology; D009249:NADP / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology*; D010710:Phosphates; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013395:Sucrose; D013997:Time Factors; D014020:Tissue Extracts
D002021:Buffers; D002712:Chlorides; D003470:Culture Media; D007328:Insulin; D009711:Nucleotides; D010710:Phosphates; D014020:Tissue Extracts; D009243:NAD; D000249:Adenosine Monophosphate; D009249:NADP; D013395:Sucrose; D000255:Adenosine Triphosphate; D004492:Edetic Acid; D012964:Sodium; D000242:Cyclic AMP; D011188:Potassium